$21.16
0.59[2.87%]
At close: Apr 19
$21.16
0[0.00%]
After Hours: 4:00PM EDT
Prothena Corp
(NASDAQ:PRTA)Prothena Corp Stock (NASDAQ:PRTA), Analyst Ratings, Price Targets, Predictions
Prothena Corp PLC has a consensus price target of $61.29, established from looking at the 54 latest analyst ratings. The last 3 analyst ratings were released from Cantor Fitzgerald, HC Wainwright & Co., and Oppenheimer on April 10, 2024, March 13, 2024, and February 20, 2024. With an average price target of $56.67 between Cantor Fitzgerald, HC Wainwright & Co., and Oppenheimer, there's an implied 167.80% upside for Prothena Corp PLC from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Cantor Fitzgerald
HC Wainwright & Co.
Oppenheimer
JMP Securities
RBC Capital
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Prothena Corp
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/10/2024 | PRTA | Buy Now | Prothena Corp | $21.16 | — | Cantor Fitzgerald | Charles Duncan | — | Reiterates | → Overweight | Get Alert |
| 03/13/2024 | PRTA | Buy Now | Prothena Corp | $21.16 | 325.33% | HC Wainwright & Co. | Andrew Fein | $90 → $90 | Maintains | Buy | Get Alert |
| 02/20/2024 | PRTA | Buy Now | Prothena Corp | $21.16 | 278.07% | Oppenheimer | Jay Olson | $98 → $80 | Maintains | Outperform | Get Alert |
| 02/16/2024 | PRTA | Buy Now | Prothena Corp | $21.16 | 301.7% | JMP Securities | Jason Butler | $81 → $85 | Maintains | Market Outperform | Get Alert |
| 02/16/2024 | PRTA | Buy Now | Prothena Corp | $21.16 | 65.41% | RBC Capital | Brian Abrahams | $36 → $35 | Maintains | Sector Perform | Get Alert |
| 01/30/2024 | PRTA | Buy Now | Prothena Corp | $21.16 | 79.58% | B of A Securities | Tazeen Ahmad | $68 → $38 | Downgrade | Buy → Neutral | Get Alert |
| 01/25/2024 | PRTA | Buy Now | Prothena Corp | $21.16 | 70.13% | RBC Capital | Brian Abrahams | $43 → $36 | Maintains | Sector Perform | Get Alert |
| 01/09/2024 | PRTA | Buy Now | Prothena Corp | $21.16 | 311.15% | Cantor Fitzgerald | Charles Duncan | $129 → $87 | Maintains | Overweight | Get Alert |
| 12/18/2023 | PRTA | Buy Now | Prothena Corp | $21.16 | 509.64% | Cantor Fitzgerald | Charles Duncan | → $129 | Reiterates | Overweight → Overweight | Get Alert |
| 12/12/2023 | PRTA | Buy Now | Prothena Corp | $21.16 | 193.01% | Deutsche Bank | Neena Bitritto-Garg | → $62 | Initiates | → Buy | Get Alert |
| 11/03/2023 | PRTA | Buy Now | Prothena Corp | $21.16 | 282.8% | JMP Securities | Jason Butler | $83 → $81 | Maintains | Market Outperform | Get Alert |
| 10/23/2023 | PRTA | Buy Now | Prothena Corp | $21.16 | 509.64% | Cantor Fitzgerald | Charles Duncan | → $129 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | PRTA | Buy Now | Prothena Corp | $21.16 | 509.64% | Cantor Fitzgerald | Charles Duncan | → $129 | Reiterates | Overweight → Overweight | Get Alert |
| 08/04/2023 | PRTA | Buy Now | Prothena Corp | $21.16 | 325.33% | HC Wainwright & Co. | Andrew Fein | → $90 | Reiterates | Buy → Buy | Get Alert |
| 08/04/2023 | PRTA | Buy Now | Prothena Corp | $21.16 | 292.25% | JMP Securities | Jason Butler | $82 → $83 | Maintains | Outperform | Get Alert |
| 07/18/2023 | PRTA | Buy Now | Prothena Corp | $21.16 | 509.64% | Cantor Fitzgerald | Charles Duncan | → $129 | Reiterates | Overweight → Overweight | Get Alert |
| 07/18/2023 | PRTA | Buy Now | Prothena Corp | $21.16 | 325.33% | HC Wainwright & Co. | Andrew Fein | → $90 | Reiterates | Buy → Buy | Get Alert |
| 07/11/2023 | PRTA | Buy Now | Prothena Corp | $21.16 | 509.64% | Cantor Fitzgerald | Charles Duncan | → $129 | Reiterates | Overweight → Overweight | Get Alert |
| 07/11/2023 | PRTA | Buy Now | Prothena Corp | $21.16 | 287.52% | JMP Securities | Jason Butler | → $82 | Reiterates | Market Outperform → Market Outperform | Get Alert |
FAQ
What is the target price for Prothena Corp (PRTA)?
The latest price target for Prothena Corp (NASDAQ: PRTA) was reported by Cantor Fitzgerald on April 10, 2024. The analyst firm set a price target for $0.00 expecting PRTA to fall to within 12 months (a possible -100.00% downside). 27 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Prothena Corp (PRTA)?
The latest analyst rating for Prothena Corp (NASDAQ: PRTA) was provided by Cantor Fitzgerald, and Prothena Corp reiterated their overweight rating.
When was the last upgrade for Prothena Corp (PRTA)?
The last upgrade for Prothena Corp PLC happened on September 28, 2022 when B of A Securities raised their price target to N/A. B of A Securities previously had a neutral for Prothena Corp PLC.
When was the last downgrade for Prothena Corp (PRTA)?
The last downgrade for Prothena Corp PLC happened on January 30, 2024 when B of A Securities changed their price target from $68 to $38 for Prothena Corp PLC.
When is the next analyst rating going to be posted or updated for Prothena Corp (PRTA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Prothena Corp, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Prothena Corp was filed on April 10, 2024 so you should expect the next rating to be made available sometime around April 10, 2025.
Is the Analyst Rating Prothena Corp (PRTA) correct?
While ratings are subjective and will change, the latest Prothena Corp (PRTA) rating was a reiterated with a price target of $0.00 to $0.00. The current price Prothena Corp (PRTA) is trading at is $21.16, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.